Attached files

file filename
EX-31.1 - CERTIFICATION - Compass Therapeutics, Inc.f10q1219ex31-1_oliviavent.htm
10-Q - QUARTERLY REPORT - Compass Therapeutics, Inc.f10q1219_oliviaventures.htm

Exhibit 32.1

 

CERTIFICATION

 

In connection with the quarterly report of Olivia Ventures, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2019 as filed with the Securities and Exchange Commission (the “Report”), I, Ian Jacobs, Chief Executive Officer and President (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: February 13, 2020

 

/s/ Ian Jacobs  
Ian Jacobs  
Chief Executive Officer and President  
(Principal Executive Officer)  
Chief Financial Officer  
(Principal Financial Officer)